lexiara

anx_I__cpt_10__point_58__text_1

A description of the content of the labelling of the investigational medicinal product in accordance with Annex VI shall be provided.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.